A new consumer-focused medical artificial intelligence (AI) platform, Savva, is set for its global launch on 7 July, with Ghana identified as one of the company’s strategic priority markets over the coming years as it seeks to expand healthcare access for underserved populations.
The company announced that its application will be available on both iOS and Android devices in more than 70 countries and support 40 languages, offering what it describes as an affordable and privacy-focused approach to digital healthcare.
Savva said its long-term mission is to digitise healthcare for one billion underrepresented people worldwide by enabling individuals to store, organise and better understand their medical information directly on their smartphones.
A key feature of the platform is its on-device optical character recognition (OCR) technology, which converts paper-based medical documents, including laboratory reports, doctors’ letters and prescription labels, into structured digital health records.
The technology functions in 40 languages and operates entirely on users’ devices, eliminating the need to upload sensitive medical information to external servers.
According to the company, the application requires no user accounts, does not rely on cloud storage and does not store personal health data on external servers, a design intended to strengthen user privacy.
Savva also aims to make advanced AI-powered medical assistance more affordable. The company said users can securely access leading AI models by integrating their health records through an anonymised system with strict policies that prevent personal data from being stored or used to train AI models.
In addition to digitising medical records, the application enables users to monitor key health indicators and integrate data from wearable health devices, bringing medical records, health metrics and AI-powered insights together in a single mobile platform.
The company noted that, in the United States, it already connects directly to health records from more than 280,000 healthcare sites and plans to establish similar integrations in other countries over time. Until such connections become available, its OCR technology is designed to create digital health records from paper documents regardless of location.
Savva has adopted a low-cost subscription model, pricing the service at less than $10 dollars per year in the United States and below $4 dollars annually in lower-resource markets to improve accessibility.
The company was founded by Stephen Rouse and Amit Shah, who previously built Protocol First, one of the early clinical health-record applications. The business was acquired by Roche in 2021. Savva represents the founders’ latest effort to expand access to digital healthcare through artificial intelligence while maintaining strong privacy protections.
